We conducted a primary research via Telephone In-Depth Interview (TIDI).
The research targeted Product, Marketing & Sales Managers/Directors – Molecular Diagnostic Manufacturers (e.g. Abbott, BD etc.) and Distributors.
The Length of Interview was around 45-60 minutes.
The study was conducted across APAC (India, China, Japan, Australia, Singapore).
The interview consisted of questions on restraints for the market, percentage contribution of Virology, HAIs, Sexual Health and Women Health and MTB in the market, current scenario and future predictions of Lab PCR market and POC Molecular Diagnostic market.
The study also focused on leading molecular diagnostic tests manufacturers (for analyzers, reagent kits and controls), funding scenario of the tests, reimbursement policy, healthcare regulations and future focus with regards to molecular diagnostics, USPs of different types of equipment and reagents sold by companies for these tests and the impact of COVID-19 on the market dynamics.
We deployed a specialist team of native and experienced non-native researchers in medtech and in-vitro diagnosyits industry